S-8184
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for S-8184, covering 2009-06-04 to 2009-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer [Phase 2]